Skip to main content
Presentation
Predicting Drug Cost Under the Medicare Part D Benefit
American Public Health Association Annual Meeting
  • Rajul A. Patel, University of the Pacific
  • Mark P. Walberg, University of the Pacific
  • Aesun Kim, University of the Pacific
  • Yvonne Mai, University of the Pacific
  • Justin Seo, University of the Pacific
  • Nataliya McElroy, University of the Pacific
  • Anil Mallya, University of the Pacific
  • Joseph A. Woelfel, University of the Pacific
  • Sian M. Carr-Lopez, University of the Pacific
  • Suzanne M. Galal, University of the Pacific
Document Type
Poster
Organization
American Public Health Association (APHA)
Location
San Francisco, CA
Conference Dates
October 27-31, 2012
Date of Presentation
10-29-2012
Abstract

Objectives: In 2012, beneficiaries in every state have at least 25 different stand-alone prescription drug plans from which to choose to receive their prescription drug coverage. We sought to create a regression model to identify factors which help predict the estimated annual costs (EAC) of the lowest cost Part D plan for beneficiaries in 2012. Methods: Targeted community outreach events were held at 13 sites between October and December 2011 during which Medicare beneficiaries were provided Part D plan assistance. A survey was used to collect and record Part D plan cost data that was retrieved subsequent to a personalized plan search (conducted on www.medicare.gov) during each intervention. Additionally, beneficiary-specific data were collected. A linear regression model via the Stepwise method was created in which EAC was the dependent variable and potential cost drivers were independent predictors. Results: Data from 362 beneficiaries were used to create the regression model. Three factors were identified as significant predictors of EAC including number of prescription medications, subsidy status, and age. Low degrees of multicollinearity were found between variables comprising the final model. Additionally, the final model coefficient of determination revealed that 29.1% of the variance in EAC could be explained by the included independent variables. Conclusions: Although certain variables are reliable for predicting plan cost, most of the variance in the EAC of the lowest cost plan was unexplained. This further supports the beneficiary-specific nature of optimal Part D plan selection and reinforces the need for annual plan evaluation to minimize out-of-pocket costs

Citation Information
Rajul A. Patel, Mark P. Walberg, Aesun Kim, Yvonne Mai, et al.. "Predicting Drug Cost Under the Medicare Part D Benefit" American Public Health Association Annual Meeting (2012)
Available at: http://works.bepress.com/joseph-woelfel/85/